Zobrazeno 1 - 10
of 340
pro vyhledávání: ''
Publikováno v:
Lung Cancer. 158:47-54
Objectives As a poor prognostic factor, visceral pleural invasion (VPI) was incorporated into non-small cell lung cancer (NSCLC) staging system. For modifying the T description of NSCLC, the prognostic value of VPI was assessed. Materials and Methods
Autor:
Maximilian von Laffert, Julian M. M. Rogasch, Jens-Carsten Rückert, Liza Michaels, Christian Furth, Sebastian Ochsenreither, Dirk Böhmer, Bettina Temmesfeld-Wollbrück, Nikolaj Frost, Holger Amthauer, Jens Neudecker, Stephanie Bluemel, Tobias Penzkofer
Publikováno v:
Lung Cancer. 157:66-74
Objectives In patients with NSCLC, current ESTS and ESMO guidelines recommend invasive lymph node (LN) staging with EBUS-TBNA even if FDG-PET/CT is negative for mediastinal LNs if at least one of three risk factors is present (cN1, non-peripheral pri
Autor:
Ariana Pereira García, Christian Rolfo, Luis E. Raez, Andrés F. Cardona, Luis Lara-Mejía, Alejandro Aviles Salas, Enrique Caballé Pérez, Oscar Arrieta, Diego Díaz-García, Ixel Escamilla, Rafael Rosell
Publikováno v:
Repositorio U. El Bosque
Universidad El Bosque
instacron:Universidad El Bosque
Universidad El Bosque
instacron:Universidad El Bosque
Introduction Brain metastases (BM) are frequent among lung cancer patients, affecting prognosis and quality of life. The International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS) and European Respiratory Society
Autor:
Paula Fontes Asprino, Cibele Masotti, Mariane Tami Amano, Leonardo Abreu Testagrossa, Dean Pavlick, Gilberto de Castro Junior, Fabiano de Almeida Costa
Publikováno v:
Lung Cancer. 154:146-150
Objectives Gene fusions are becoming more evident in cancer scenario for either being the driver alterations, or for the great therapeutic target potential in many cases. Our aim was to characterize the BRD4-NOTCH3 fusion correlating with clinical fe
Autor:
Marco Lucchi, Lorena Costardi, Angelo Morelli, Domenico Viggiano, Angela De Palma, Filippo Tommaso Gallina, Michele Rusca, Giovanni Muriana, Silvia Ceccarelli, Andrea De Vico, Lorenzo Spaggiari, Giuseppe Marulli, Roberto Crisci, Angelo Carretta, Lorenzo Rosso, Enrico Ruffini, Paolo Mendogni, Francesco Puma, Luigi Ventura, Francesco Londero, Luca Bertolaccini, Edoardo Bottoni, Federico Rea, Marco Alloisio, Giuseppe Cardillo, Marco Schiavon, Maria Teresa Congedo, Nicola Tamburini, Pio Maniscalco, Giampiero Negri, Francesco Facciolo, Sara Ricciardi, Stefano Margaritora, Stefano Bongiolatti, Ilaria Ceccarelli, Luca Voltolini
Publikováno v:
Lung Cancer. 154:29-35
Backgrounds Oligometastatic Non-Small Cell Lung Cancer (NSCLC) patients represent a category without a standard therapeutic approach. However, in selected oligometastatic NSCLC, radical surgery seems to offer a good prognosis. This retrospective stud
Autor:
Maria Mayoral, Jose de Arimateia Batista Araujo-Filho, Stephanie Lobaugh, Natasha Rekhtman, Jason C. Chang, Junting Zheng, Andrew J. Plodkowski, Michelle S. Ginsberg, Rocio Perez-Johnston, Valerie W. Rusch
Publikováno v:
Lung Cancer
OBJECTIVES: Distinguishing separate primary lung carcinomas (SPLCs) from intrapulmonary metastases (IPMs) in non-small cell lung cancer (NSCLC) patients is a challenging dilemma in clinical practice. Next-generation sequencing (NGS) was recently show
Autor:
Bingjie Fan, Shijiang Wang, Jinming Yu, B. Li, Wanlong Li, Dai Zhang, Linlin Wang, Bing Zou, Xuanzong Li
Publikováno v:
Lung Cancer. 151:39-43
B-cell lymphoma 2-like 11 (BCL-2-like 11, BCL2L11, also known as BIM) deletion polymorphism (BIM-del) has been associated with resistance to first-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), and is a poor progn
Autor:
Thomas Tsitsias, Tom Routledge, John Pilling, Lukacs Veres, Lawrence Okiror, Juliet King, Karen Harrison-Phipps, Andrea Bille
Publikováno v:
Lung Cancer. 151:84-90
Objective to validate the proposed N descriptor revision on a large cohort of patients and assess the impact of tumour location on the distribution pattern of lymph node metastases for patients with NSCLC. Methods This is a retrospective review of a
Autor:
Vlatka Smoljanovic, S Gally, Pascale Tomasini, Adam Gondos, Stefan Hammerschmidt, Gracy Crane, Nasreen Khan, Nuria Lara
Publikováno v:
Lung Cancer. 149:144-153
Objectives Quantify the burden of central nervous system (CNS) metastases on health-related quality of life (HRQoL) and healthcare resource use (HRU) in patients with advanced non-small-cell lung cancer (NSCLC) from a prospective European study in cl
Autor:
Shoichi Mori, Hisao Asamura, Ichiro Yoshino, Yasushi Shintani, Hiroshi Date, Etsuo Miyaoka, Meinoshin Okumura, Jiro Okami, Takashi Ohtsuka, Masayuki Chida, Ryoichi Nakanishi, Takeshi Nagayasu, Hiroyuki Ito, Takeshi Mori, Koichi Fukumoto, Shinichi Toyooka, Shunsuke Endo, Shun Ichi Watanabe
Publikováno v:
Lung Cancer. 149:120-129
The aim of this study was to evaluate the impact of the preoperative body mass index (BMI) on the postoperative outcomes in patients with completely resected non-small cell lung cancer (NSCLC).The data of patients with NSCLC in whom R0 resection was